Crescita Therapeutics

(OTC) CRRTF

Current Price$0.56

Market Cap$10.42M

Since IPO (2016)-52%

5 Year-20%

1 Year+44%

1 Month+4%

Crescita Therapeutics Financials at a Glance

Market Cap

$10.42M

Revenue (TTM)

$21.11M

Net Income (TTM)

$91.42K

EPS (TTM)

$-0.00

P/E Ratio

-266.67

Dividend

$0.00

Beta (Volatility)

-0.56 (Low)

Dividend

$0.00

Beta (Volatility)

-0.56 (Low)

Price

$0.56

Volume

20,000

Open

$0.56

Price

$0.56

Volume

20,000

Open

$0.56

Previous Close

$0.56

Daily Range

$0.56 - $0.56

52-Week Range

$0.02 - $0.56

Dividend

$0.00

Beta (Volatility)

-0.56 (Low)

Price

$0.56

Volume

20,000

Open

$0.56

Previous Close

$0.56

Daily Range

$0.56 - $0.56

52-Week Range

$0.02 - $0.56

CRRTF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Crescita Therapeutics

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Serge Verreault, MBA

Website

www.crescitatherapeutics.com

Headquarters

Laval, QC H7V 0A3, CA

CRRTF Financials

Key Financial Metrics (TTM)

Gross Margin

54%

Operating Margin

-5%

Net Income Margin

-0%

Return on Equity

-33%

Return on Capital

-7%

Return on Assets

-0%

Earnings Yield

-0.37%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$10.42M

Shares Outstanding

18.61M

Volume

20.00K

Avg. Volume

2.03K

Financials (TTM)

Gross Profit

$10.36M

Operating Income

$1.02M

EBITDA

$478.61K

Operating Cash Flow

$1.07M

Capital Expenditure

$332.73K

Free Cash Flow

$739.40K

Cash & ST Invst.

$8.57M

Total Debt

$333.73K

Crescita Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$5.95M

-13.8%

Gross Profit

$3.03M

+1.3%

Gross Margin

50.98%

N/A

Market Cap

$10.42M

N/A

Market Cap/Employee

$146.81K

N/A

Employees

N/A

Net Income

$710.42K

-338.5%

EBITDA

$29.98K

-85.3%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$8.24M

-2.4%

Accounts Receivable

$2.11M

+33.4%

Inventory

$4.72M

+16.5%

Long Term Debt

$0.00

-100.0%

Short Term Debt

$333.73K

-28.8%

Return on Assets

-0.45%

N/A

Return on Invested Capital

-6.55%

N/A

Free Cash Flow

$1.14M

+11.3%

Operating Cash Flow

$415.66K

-69.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

BGXXBright Green Corporation

BGXXBright Green Corporation$0.04+5328.57%

CVSICV Sciences, Inc.

CVSICV Sciences, Inc.$0.03+1.69%

UNVCUnivec, Inc.

UNVCUnivec, Inc.$0.00-4.31%

DHBUFDelivra Health Brands Inc.

DHBUFDelivra Health Brands Inc.$0.11-9.57%

HYEXHealthy Extracts Inc.

HYEXHealthy Extracts Inc.$1.12+0.00%

TWSITristar Wellness Solutions Inc.

TWSITristar Wellness Solutions Inc.$0.06+0.00%

AYRWFAyr Wellness Inc.

AYRWFAyr Wellness Inc.$0.01-4.76%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

SOFISoFi Technologies

SOFISoFi Technologies$16.43+0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

TSLATesla

TSLATesla$390.82+0.02%

NIONio

NIONio$5.91-0.08%

Questions About CRRTF

What is the current price of Crescita Therapeutics?

Crescita Therapeutics is trading at $0.56 per share.

What is the 52-week range for Crescita Therapeutics?

Over the past 52 weeks, Crescita Therapeutics has traded between $0.02 and $0.56.

How much debt does Crescita Therapeutics have?

As of the most recent reporting period, Crescita Therapeutics reported total debt of $243,662.229.

How much cash does Crescita Therapeutics have on hand?

Crescita Therapeutics reported $6.26M in cash and cash equivalents in its most recent financial results.

What is Crescita Therapeutics’s dividend yield?

Crescita Therapeutics does not currently have a dividend yield.

Crescita Therapeutics

Crescita Therapeutics Financials at a Glance

CRRTF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Crescita Therapeutics

CRRTF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Crescita Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CRRTF

What is the current price of Crescita Therapeutics?

What is the 52-week range for Crescita Therapeutics?

How much debt does Crescita Therapeutics have?

How much cash does Crescita Therapeutics have on hand?

What is Crescita Therapeutics’s dividend yield?

Premium Investing Services